RFG
MRNA icon

RFP Financial Group’s Moderna MRNA Stock Holding History

RFP Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-65
Closed -$7.72K – 528
2024
Q2 		$7.72K Buy
65
+3
+5% +$380 ﹤0.01% 479
2024
Q1 		$6.61K Sell
62
-39
-39% -$3.93K ﹤0.01% 468
2023
Q4 		$10K Buy
101
+43
+74% +$3.62K ﹤0.01% 409
2023
Q3 		$5.99K Hold
58
– – ﹤0.01% 480
2023
Q2 		$7.05K Hold
58
– – ﹤0.01% 489
2023
Q1 		$8.91K Sell
58
-50
-46% -$8.25K 0.01% 294
2022
Q4 		$19.4K Buy
+108
New +$17.7K 0.01% 287

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RFP Financial Group's MRNA Position: Q3 2024 in Review

RFP Financial Group sold out of Moderna (MRNA) in Q3 2024, closing a stake of 65 shares — an estimated $7.72K sold.

RFP Financial Group first reported a position in MRNA in Q4 2022 and held it in 7 quarters. The position peaked at $19.4K in Q4 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • RFP Financial Group reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 65 Moderna shares in Q3 2024, an estimated $7.72K.
  • RFP Financial Group first reported a position in Moderna in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Moderna position peaked at $19.4K in Q4 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.